Literature DB >> 29518850

[Comprehensive identification of compensatory mutations in rifampicin-resistant Mycobacterium tuberculosis strains].

T Y Zuo1, Q Y Liu, M Y Gan, Q Gao.   

Abstract

Objective: To comprehensively identify compensatory mutations in rpoA, rpoB and rpoC genes of rifampicin-resistant Mycobacterium tuberculosis (RIF-r MTB) and to evaluate the effect of rifampicin-resistant mutation type and lineage background on occurrence of compensatory mutations.
Methods: Published MTB whole genome sequencing data were searched and downloaded. RIF-r MTB was identified through known rifampicin-resistant mutations. Based on parallel evolutionary patterns, we identified putative compensatory mutations in the phylogenetic tree and calculated proportions of accumulating compensatory mutations in each rifampicin-resistant mutations' type and lineage background of RIF-r MTB. Statistic significance was analyzed by chi-square test.
Results: A total of 8 453 global MTB whole genome sequencing data were downloaded form ENA (covering 12 countries), including 1 749 RIF-r MTB. Based on phylogenetic analysis, we totally identified 60 putative compensatory mutations (6 in rpoA gene, 16 in rpoB gene and 38 in rpoC gene), 11 of which were newly reported. RIF-R strains carrying rpoB S450L (41.7%, 279/669) had a significant higher chance to accumulate compensatory mutations than strains with other rpoB mutations (8.0%, 31/388, χ(2)=378.5, P<0.000 1). In addition, RIF-R strains from lineage 2 (34.0%, 223/656) had a significant higher chance to accumulate compensatory mutations than strains from other lineages [lineage1: 4.7%(2/43), 2/43, lineage3: 12.5%(4/32), 4/32, lineage4: 15.1%(78/517), 78/517; χ(2)=238.5, P<0.000 1]. Conclusions: Our study comprehensively identified putative rifampicin-resistant compensatory mutations of rifampicin resistance. RIF-R strains carrying rpoB S450L mutation or from lineage 2 had a significantly higher chance to accumulate compensatory mutations than strains either with other rpoB mutations or from other lineages.

Entities:  

Keywords:  Drug resistance; Mutations; Mycobacterium tuberculosis; Rifampin

Mesh:

Substances:

Year:  2018        PMID: 29518850     DOI: 10.3760/cma.j.issn.1001-0939.2018.03.012

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  2 in total

1.  Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population.

Authors:  S A Hadi; I V Kolte; E P Brenner; E A T Cunha; V Simonsen; L Ferrazoli; D A M Villela; R S Santos; J Ravi; S Sreevatsan; P C Basta
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

2.  Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.

Authors:  Selien Oostvogels; Serej D Ley; Tim H Heupink; Anzaan Dippenaar; Elizabeth M Streicher; Elise De Vos; Conor J Meehan; Keertan Dheda; Rob Warren; Annelies Van Rie
Journal:  Microb Genom       Date:  2022-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.